Key result
ARC-HBR status is linked to higher bleeding and major cardiovascular events risks across Black and White cohorts.
Why the study?
Do the ARC-HBR criteria accurately predict bleeding and thrombotic events in self-identified Black patients undergoing PCI?
Observational (n=9,462)
No
Do the ARC-HBR criteria accurately predict bleeding and thrombotic events in self-identified Black patients undergoing PCI?
The ARC-HBR criteria effectively predict bleeding and thrombotic risks in both Black and White patients undergoing PCI, validating its clinical utility across these racial groups.
Answers are grounded in this paper and cite their sources.
ARC-HBR criteria may aid risk assessment across races in PCI; extends validation to Black patients yet leaves open randomized confirmation.
BACKGROUND: Whether the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria are a valuable tool for risk stratification in self-identified Black patients undergoing percutaneous coronary intervention (PCI) remains uncertain. AIMS: This study aims to assess the predictive ability of the ARC-HBR criteria in patients who identify as Black and White. METHODS: Consecutive patients undergoing PCI at a large tertiary-care center from 2012 to 2019, and self-reporting as Black or White, were included in the current retrospective observational analysis and stratified into HBR and non-HBR based on the ARC-HBR definition. The primary outcome was all-bleeding, defined as a composite of peri-procedural in-hospital and post-discharge bleeding at 1-year follow-up. Secondary outcomes included post-discharge bleeding, major adverse cardiovascular events (MACE)-a composite of all-cause death, myocardial infarction, or stroke- and its individual components. The discriminative ability of the ARC-HBR criteria to predict outcomes was computed using Harrell's C-index. RESULTS: Among 9462 patients included, 1881 (19.9%) identified as Black and 7581 (80.1%) as White. In these two groups, 50.8% of Black and 45.6% of White patients were classified as HBR, and a different distribution of the individual major and minor criteria was observed. Within the Black cohort, HBR was associated with a significantly higher risk of the primary bleeding endpoint, MACE, and all-cause mortality, with only a trend toward a higher rate of post-discharge bleeding and MI. Conversely, among White patients, HBR was associated with a significantly higher risk of the primary bleeding endpoint, as well as all secondary endpoints. These findings were confirmed after multivariable adjustment, with no significant interaction between race and HBR status with regard to outcomes. CONCLUSIONS: In this contemporary PCI registry, the ARC-HBR criteria showed a good ability in identifying patients at increased risk of bleeding and thrombotic events, irrespective of self-reported Black or White race.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2025) conducted an observational in Percutaneous coronary intervention (n=9,462). High Bleeding Risk (HBR) by ARC-HBR criteria vs. Non-HBR was evaluated on All-bleeding (composite of peri-procedural in-hospital and post-discharge bleeding). Among 9,462 patients undergoing PCI, high bleeding risk by ARC-HBR criteria was associated with higher risk of bleeding and major cardiovascular events in both Black and White cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: